O-T
David Palma
MD, PhD; Radiation Oncology, Cross Appointment to Medical Biophysics and Otolaryngology - Head and Neck SurgeryResearch Interests / Specializations: Dr. Palma's research focuses on translational imaging science, including evaluating new imaging and radiotherapy technologies in the pre-clinical and clinical setting.
Brian Pagenkopf
PhD. Professor, Department of Chemistry: Organic Teaching Division, Western University.Research Interests / Specializations: Organic Synthesis
Armen Parsyan
MD, PhD, DSc, MPH, FRCSC. General Surgeon and Breast Surgical Oncologist. Assistant Professor, Departments of Surgery, and Oncology, Schulich School of Medicine and Dentistry, Western University. Clinician-Scientist, Lawson Health Research InstituteResearch Interests / Specializations: Translational Breast Cancer Research, Patent-Derived in Vitro and In Vivo Models of Breast Cancer, Studies of Novel Multimodality Treatments in Patient-Derived Preclinical Models, Models of Brain Metastases in Breast Cancer, Mechanisms of Breast Cancer Development and Progression, Non-Inferiority Clinical Trials in Surgical Oncology.
Silvia Penuela
PhD. Associate Professor, Depts. of Anatomy and Cell Biology, and Oncology Division of Experimental Oncology. Schulich School of Medicine and Dentistry, Western University.Research Interests / Specializations: Biochemistry and cell biology of pannexins in cancer.
Francisco Perera
BSc. ENG. MD. FRCP(C). Associate Professor in Radiation Oncology, Western University. Radiation Oncologist, London Regional Cancer ProgramResearch Interests / Specializations: Extensive experience in clinical trials for breast and gastrointestinal malignancies. Key collaborator in the design and completion of clinical trials in breast cancer in collaboration with the Ontario Clinical Oncology Group and the National Cancer Institute of Canada.
Terry Peters
PhD, FRSC. Professor Emeritus, Department of Medical Biophysics, and Medical Imaging and Biomedical Engineering.Research Interests / Specializations: Image-guided surgery; 3-D visualization, non-linear image warping, instrument tracking, multi-modality image registration, brain imaging, cardiac imaging, stereoscopic visualization and virtual reality.
Jim Petrik
PhD. Professor, Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph. Adjunct Professor, Department of Oncology, Schulich School of Medicine & Dentistry, Western University.Research Interests / Specializations: Female reproductive biology and ovarian cancer. Developing novel therapeutics for treatment of late stage ovarian cancer. Focusing on anti angiogenic therapies for inhibiting new growth of blood vessels supplying the tumours.
Christopher Pin, PhD.
Professor, Departments of Physiology and Pharmacology, Oncology and Paediatrics Schulich School of Medicine and Dentistry University of Western Ontario Distinguished Scientist, Verspeeten Family Cancer Centre London Health Sciences Centre Director, Living Biobank for Cancer Research.Research Interests / Specializations: PI, CIHR and NSERC funding on pancreatic cancer; Molecular Biology; Epigenetics; Animal modeling of cancer
Lisa Porter
PhD. Professor, Department of Biomedical Sciences, University of Windsor. Executive Director, WE-SPARK Health Institute.Research Interests / Specializations: Molecular/cell biology as it pertains to cancer biology and links to normal development. Focus on cell cycle and cell growth regulation in breast, brain, liver, prostate cancer. Uses mouse and zebrafish models as well as cell lines and patient-derived samples and clinical data.
Nicholas Power
MD; Surgery: Urology, OncologyResearch Interests / Specializations: Clinical care; Translational research; Prostate, renal, testicular cancer; tumor banking
Frank Prato
PhD, FCCPM, ABMP, FCOMP, FURSI, FCAHSResearch Interests / Specializations: Research Imaging Program Leader , Assistant Scientific Director, Lawson Health Research Institute Dr. Frank Prato has completed implementation of a $30 million grant for molecular and hybrid imaging facilities including, as of Feb 7 2012, the first PET/MRI whole body hybrid imaging platform in Canada. He has expertise in both nuclear medicine imaging and magnetic resonance imaging (MRI) and has published over 210+ scientific papers. With a team of 31 researchers, the Lawson Imaging program is a recognized leader in non-invasive biomedical imaging. Hybrid imaging (which combines two or more imaging methods to provide superior images and diagnostic information) is currently being applied to the areas of cardiology, neurology (including mental health), metabolic disease and cancer.
Douglas Quan
MD. RCPSC. Associate Professor, Department of Surgery, Western University. Associate Scientist, Lawson Research Institute.Research Interests / Specializations: Liver disorders.
Jacques Raphael
MD, MSc. Medical Oncologist, London Regional Cancer Program. Assistant Professor of Oncology, Schulich School of Medicine & Dentistry, Western UniversityResearch Interests / Specializations: Clinical - Breast and Lung Cancer. Research - Early phase drug trials and biomarker studies. Systematic reviews/meta-analyses
Michael Rieder
MD. PhD. Professor, Department of Paediatric, Physiology & Pharmacology and Medicine at Schulich School of Medicine and Dentristy, Western University. Head, Division of Pediatric Clinical Pharmacology. Scientist, Robarts Research Institute. Member, Drug Therapy Committee of the Canadian Paediatric Scociety. Member of the Executive of the Canadian Society of Pharmacology and Therapeutics. Consultant to Health Canada, the NIH, the MRC and the College of Academies.Research Interests / Specializations: Research focuses on drug safety and adverse drug reactions as well as optimal therapeutics in children. Studies generic variations and their impact on drug efficacy and safety and the mechanims of drug hypersensitivity.
George Rodrigues
MD. PhD. FRCPC, FASTRO; Epidemiology & Biostatistics, Oncology (Radiation)Research Interests / Specializations: Radiation Oncology; Prostate & GU, Lung Cancers; Brain Metastases, Epidemiology & Biostatistics: Markov modeling; Database analysis, Clinical Trials
John Ronald
PhD. Associate Professor, Department of Medical Biophysics. Scientist, Robarts Research Institute. Associate Scientist, Lawson Health Research Institute.Research Interests / Specializations: Research focusees on pioneering novel molecular and cellular imaging technologies. Specific interest on improving early cancer detection, improved monitoring state-of-the-art gene-based and cell-based therapies for cancer and other disease.
Kathryn Roth
MD. RCPSC. Associate Professor, Departments of Otolaryngology - Head & Neck Surgery, Director Undergraduate Medical Education, Schulich School of Medicine & Dentistry, Western University. Surgeon, St. Joseph's Hospital.Research Interests / Specializations: Melanoma, sentinel node biopsy, tumour molecular expression in advanced cutaneous carcinoma, thyroid cancer prognostication, medical education simulation and skill acquisition.
Bekim Sadikovic
PhD. DABMG (Cyto;Mol), FACMG. Clinical Molecular Geneticist, Clinical Cytogeneticist.Research Interests / Specializations: Division Head, Molecular Diagnostics Division, Pathology and Laboratory Medicine; Professor, Pathology and Laboratory Medicine; Molecular Diagnostics, Genomics, Epigenomics, Hereditary and Somatic Oncology, Computational Biology, Machine Learning, Big Data
Caroline Schild-Poulter
PhD; BiochemistryResearch Interests / Specializations: Mechanisms of cancer development; Cellular response to DNA damage
Timothy Scholl
PhD; Associate Professor, Department of Medical Biophysics, Western University. Scientist, Imaging Research Laboratories, Robarts Research Institute, Western University. Investigator, Ontario Institute for Cancer Research.Research Interests / Specializations: Research focus on measuring cancer metabolism with magnetic resonance imaging. Specific interests in characterizing human prostate cancer with sodium MRI and development of hyperpolarized 13C magnetic resonance spectroscopic imaging for assessing therapeutic response in pre-clinical models of glioma.
Trevor Shepherd
Translational Oncology Scientist, London Regional Cancer Program. Associate Professor, Ob/Gyn, Oncology and Anatomy & Cell BiologyResearch Interests / Specializations: Ovarian cancer; metastasis; 3D spheroid; patient-derived samples; cell signalling; tumour dormancy; therapeutics testing
Brian Shilton
Ph.D.; Professor, Department of Biochemistry Director of Macromolecular Crystallography FacilityResearch Interests / Specializations: Molecular structure and enzyme mechanism; molecular dynamics; nicotinamide function and metabolism; drug interactions; quinone reductases 1 and 2; Pin1 peptidyl prolyl isomerase; p53 tumor suppressor; 20S proteosome
Parisa Shooshtari
PhD. Assistant Professor, Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, Western University. Scientist, Ontario Institute for Cancer Research (OICR). Scientist, Child Health Research Institute (CHRI).Research Interests / Specializations: Bioinformatics, Computational Biology, Multi-Omics, Data Integration, Machine Learning, Single-cell Sequencing, Epigenetic.
Krishna Singh
PhD. Assistant Professor, Department of Medical Biophysics, Western University.Research Interests / Specializations: Autophagy, DNA damage and repair, endothelial-to-mesenchymal transition, cardiovascular diseases and organ fibrosis.
Peter Stathopulos
PhD. Associate Professor, Department of Physiology and Pharmacology, Western University.Research Interests / Specializations: Structural biology; calcium signaling; molecular pharmacology; protein folding; ion channels; SOCE; mitochondrial Ca2+;cancer; heart disease; immunodeficiency.
Michael Strong
MD, FRCP(C), FANN, FCAHS, Professor of Neurology, Western University. President, Canadian Institute of Health Research.Research Interests / Specializations: Focuses on understanding the cellular biology of ALS and has led to an understanding of the mechanisms by which intracellular deposits of protein are formed, and how these aggregates contribute to the understanding of neurophychological deficits in ALS, both clinically and at the cellular level.
Jonathan D. Thiessen
PhD. Assistant Professor, Departments of Medical Biophysics and Medical Imaging, Schulich School of Medicine & Dentistry. PET/MRI Scientific Director, Lawson Research Health Institute. Scientist, Imaging Program, Lawson Health Research Institute. Associate Member, The Brain & Mind Institute, Western University.Research Interests / Specializations: PET/MRI of prostate cancer, glioma, cardiac disease, and neurodegenerative disorders.
Alexander Timoshenko
PhD, DSc. Associate Professor, Department of Biology, Western University.Research Interests / Specializations: Cancer Cell Biology; Glycobiology; Cell Biology and Biomedical Application of Galectins; Tissue-Specific Galectins and Cell Differentiation
Elena Tsvetkova
MD, FRCPC, M.Ed. Medical Oncologist, London Regional Cancer Centre. Assistant Professor, Shulich School of Medicine and Dentistry, Western University.Research Interests / Specializations: Clinical: GI, NET, Breast, GIST. Research: Pancreatic Cancer and Pancreatic Neuroendocrine Tumours.
Eva Turley
PhD; Biochemistry, Oncology (Experimental), Distinguished Oncology Scientist, LRCPResearch Interests / Specializations: Breast cancer; Cellular and molecular mechanisms of metastasis; 3D cell culture models; Translational research; Novel therapeutics. Fibrosis and inflammation in tumour microenvironments.